Curemark Competitors and Similar CompaniesClear all
Curemark's competitors and similar companies include PaxMedica, Synthorx, Incendia Therapeutics and AM Pharma.
 Curemark Curemark is a biopharmaceutical company focused on developing therapies for the treatment of neurological and other disorders. |  PaxMedica PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS). |  Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. |  Incendia Therapeutics Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment. | ||
Founding Date | Founding Date 2006 | Founding Date 2018 | Founding Date 2014 | Founding Date 2019 | Founding Date 2001 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Rye, US HQ Rye Brook, US | Locations Tarrytown, US HQ | Locations San Diego, US HQ | Locations Boston, US HQ | Locations Utrecht, NL HQ Utrecht, NL |
Employees | Employees 23 | Employees 2100% increase | Employees 3939% increase | Employees 41 | Employees 28 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.1 m | Valuation ($) 2.2 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($18.3m) (FY, 2023) | Net income ($5.9m) (FY, 2017) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 5.4m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 65m (over 4 years ago) | Latest funding round $ 24m (about 6 years ago) |
Total funding raised | Total funding raised $ 55.7m | Total funding raised N/A | Total funding raised $ 79m | Total funding raised $ 65m | Total funding raised $ 210.3m |
For sources of this data, please see the company profile
View Company Profiles
PaxMedica
HQ
Tarrytown, US
Employees
2
PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS).
View companySynthorx
HQ
San Diego, US
Employees
39↑ 39% increase
Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics.
View companyIncendia Therapeutics
HQ
Boston, US
Employees
41
Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment.
View company
AM Pharma
HQ
Utrecht, NL
Employees
28
AM-Pharma is a biopharmaceutical company that develops medicines for patients.
View company